ImmunityBio (IBRX) Jumps 18% on Anktiva Access Expansion
We recently published a list of 15 Stocks That Stole The Show Last Week. In this article, we are going to take a look at where ImmunityBio, Inc.
Immunitybio Inc. (IBRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Sculptor Capital Daniel S. Och | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.75 | 485 | $1,333.75 | 71,915 | 2023-06-05 | Filing | |
| $2.77 | 48,000 | $132,960.00 | 71,430 | 2023-06-05 | Filing | |
| $2.72 | 23,430 | $63,729.60 | 23,430 | 2023-06-05 | Filing | |
| $2.90 | 10,000 | $29,000.00 | 25,000 | 2023-06-02 | Filing | |
| $2.80 | 10,000 | $28,000.00 | 15,000 | 2023-06-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.12 | 14,801 | $149,795.00 | 200,617 | 2021-08-23 | Filing | |
| $10.00 | 9,976 | $99,807.88 | 215,418 | 2021-08-20 | Filing | |
| $10.03 | 2,133 | $21,389.08 | 225,394 | 2021-08-18 | Filing | |
| $10.12 | 43,398 | $439,361.35 | 227,527 | 2021-08-17 | Filing | |
| $16.18 | 88,787 | $1,436,822.26 | 3,102,507 | 2021-05-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Why ImmunityBio, Inc. (IBRX) Skyrocketed Today
We recently published a list of These 10 Stocks Are On Fire Right Now. In this article, we are going to take a look at where ImmunityBio, Inc.
Why ImmunityBio, Inc. (IBRX) Surged On Thursday
We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild.
Piper Sandler Upgrades ImmunityBio (IBRX) to Overweight, Lifts PT
In a research note, the analyst told investors that the rating is based on the development of the company's ANKTIVA, t-haNK & M-ceNK cell therapies, and DNA vaccines, which combat cancer by supporting...
Why ImmunityBio, Inc. (IBRX) Crashed Today
We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where ImmunityBio, Inc.
Jim Cramer Notes ImmunityBio (IBRX) Has “Been Losing Money Forever”
We recently published a list of Jim Cramer’s Recent Thoughts on These 15 Stocks.
Jim Cramer’s Recent Thoughts on These 15 Stocks
“Stories like the US debt downgrade story from Friday, they are classic… Stories that scare people out of very fine stocks that could otherwise make them rich.
10 Low Risk High Reward Stocks Set to Triple by 2030
The market is getting tough these days with increasing interest rates, tense world politics, and inconsistent economic conditions, and investors are constantly looking for opportunities.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
Billionaire Hedge Funds
